Bristol-Myers Squibb (BMY)

Index:

S&P 100

$ 44.85
   
  • Change Today:
    $0.15
  • 52 Week High: $69.08
  • 52 Week Low: $44.34
  • Currency: US Dollars
  • Shares Issued: 1,998.00m
  • Volume: 1,618
  • Market Cap: $89,610m
  • RiskGrade: 106

BMY Overview

Bristol-Myers Squibb is a global producer and distributor of pharmaceuticals and other healthcare-related products. The merger of Bristol-Myers with Squibb in 1989 created what was then the world’s second-largest pharmaceutical enterprise. The company’s key business areas cover pharmaceuticals, infant formulas and nutritional products, ostomy & advanced wound care, cardiovascular imaging and over-the-counter products.

1 Day Chart (26-04-2024)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0%
Div Cover n/a
Op Mrgn 18.8%
ROCE 40.2%
Latest F'cast
P/E 11.6
PEG 0.4
Pr/Revenue 2.0
Pr/Book 3.0
Latest F'cast
Revenue -2.5%
PBT 9.4%
EPS 30.8%
DPS n/a

BMY Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 26,145.00 4,975.00 202.00¢ 31.8 n/a -33% 168.00¢ 2.6%
31-Dec-20 42,518.00 (6,871.00) (399.00)¢ n/a n/a n/a 184.00¢ 3.0%
31-Dec-21 46,385.00 8,098.00 315.00¢ 19.8 n/a n/a 201.00¢ 3.2%
31-Dec-22 46,159.00 7,713.00 295.00¢ 24.4 n/a -6% n/a 0.0%
31-Dec-23 45,006.00 8,440.00 386.00¢ 13.3 0.4 +31% n/a 0.0%

BMY Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-24 45,977.39 4,141.41 51.61¢ 86.9 n/a -87% 243.19¢ 0.0%
31-Dec-25 46,244.14 16,930.43 695.82¢ 6.4 0.0 +1,248% 255.45¢ 0.0%
31-Dec-26 44,285.40 15,871.07 641.73¢ 7.0 n/a -8% 264.64¢ 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

BMY ShareCast News

Bristol Myers Squibb to cut 2,200 jobs as part o... 25-Apr-2024 ShareCast
Bristol Myers Squibb to buy Karuna Therapeutics ... 22-Dec-2023 ShareCast
GlaxoSmithKline denies interest in Aurinia 01-Nov-2021 ShareCast

BMY Top Newspaper Links

Bristol-Myers, partner AstraZeneca get EU approv... 06-Oct-2009 Chicago Tribune
AstraZeneca's heart attack drug offers £5.5bn bo... 31-Aug-2009 Sunday Telegraph
Astra Zeneca gets US approval for diabetes drug ... 02-Aug-2009 Sunday Times

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

BMY Market Data

Currency US Dollars
Share Price $ 44.85
Change Today $ 0.15
% Change 0.34 %
52 Week High $69.08
52 Week Low $44.34
Volume 1,618
Shares Issued 1,998.00m
Market Cap $89,610m
RiskGrade 106

What The Brokers Say

Strong Buy 3
Buy 3
Neutral 18
Sell 1
Strong Sell 0
Total 25
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 26-Apr-2024

Time Volume / Share Price
16:00 2,982,316 @ $44.85
15:59 456 @ $44.84
15:59 4,100 @ $44.84
15:59 700 @ $44.85
15:59 206 @ $44.85

Top of Page